Protein painting identifies therapeutic targets at protein-protein interfaces
蛋白质绘画识别蛋白质-蛋白质界面的治疗靶点
基本信息
- 批准号:9392299
- 负责人:
- 金额:$ 9.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAmino AcidsBindingBiological AssayCategoriesCell CommunicationCell Surface ReceptorsCell surfaceCellsChemicalsChemistryComplexConsensusCrystallizationCrystallographyDataDeuteriumDissociationDyesFaceFolliculinHot SpotHydrogenImmuneImmune Cell SuppressionImmunotherapyIn VitroLigandsMalignant NeoplasmsMapsMethodsMolecularMolecular ConformationMonoclonal AntibodiesOncogenesPDCD1LG1 genePaintPathway interactionsPeptide HydrolasesPeptide antibodiesPeptidesProductionProtein Binding DomainProtein RegionProteinsProteolysisProtocols documentationReceptor CellReceptor SignalingResolutionSideSignal TransductionSignaling ProteinSiteSolventsSpecificityStructureSuppressor GenesSurfaceTechnologyTherapeuticTimeTrypsinTumor Suppressor ProteinsValidationWestern Blottingaryl hydrocarbonschymotrypsincrosslinkdrug candidatemonoclonal antibody productionneoplastic cellnew technologynext generationnovelpointed proteinprotein complexprotein protein interactionsmall moleculesurface coatingsynthetic peptidetherapeutic targettumor
项目摘要
The next generation of molecular cancer therapeutics will target pivotal protein-protein interaction interfaces
participating in immune cell receptor signaling, oncogenes, and suppressor genes. We will implement a truly
transformative, wholly novel, technology “protein painting” for the rapid direct sequencing of hidden native
protein-protein interaction hot spots, that was originated under NCI R21 IMAT CA177535. Our technology
employs previously unexplored small molecule (12 Å) aryl hydrocarbon dyes or “paints” to cut out, and MS
sequence, only the hidden unmodified contact interfaces between two or more interacting native proteins.
Protein painting employs a completely new principle that yields a much higher specificity and three times
higher number of positive hits compared to chemical footprinting methods. Paint chemistries have extremely
high affinities (rapid on-rates, and very slow off-rates that are ten to 100 times higher than most protein-protein
interactions). When mixed with a native pre-formed protein complex for only 5 minutes, the paints non-
covalently coat all external sites on the protein without altering the 3D conformation of the complex, but cannot
gain access to the solvent inaccessible hidden protein-protein interaction domains. Each paint molecule spans
3 amino acids or less, and has high affinity for protease cleavage consensus sites. Following painting, the
unbound paints are washed away and the proteins are dissociated. This leaves the paint molecules coating
surfaces not participating in the interface. Following dissociation, the proteins are linearized, digested with
proteolytic enzymes, and sequenced by MS. The paint molecules remain non-covalently bound after the
proteins are denatured. Proteolytic enzymes such as trypsin will not cleave the regions of the protein that are
“painted”. Following proteolysis, therefore, peptides emerging from MS will exclusively be generated from the
unmodified opposing points where the proteins were in intimate contact. All of the original R21 Aims and
Milestones were fully met. A very high correlation (p<0.0003) was found between protein painting and the
contact points predicted by crystal structure, with a 97% specificity for true positive hot spots. We discovered
evolutionarily conserved 3-way hotspots and verified their functional importance by creating peptides and
mAbs that block the interaction and extinguish signaling. Under Aim1, we will discover novel hotspot
sequences of broad therapeutic relevance for interacting protein complexes of three types: 1) cell surface
receptors (PD1/PDL-1,PDL-2) involved in tumor immune cell suppression , 2) Hippo cancer suppressor
pathway proteins, and 3) the recently elucidated oncogene Folliculin.Under Aim 2 we will validate the functional
(drug candidate) importance of the interaction hotspots we discover, by creating peptides and monoclonal
antibodies that bind to the opposing hotspot faces of the interacting proteins. We will verify that these ligands
will suppress protein complex formation. For the PD1/PDL-1,PDL-2 cell surface complexes, we will extend
protein painting, for the first time, to MS sequence cell-cell interaction contact points in cultured live cells.
下一代分子癌症疗法将针对关键的蛋白质-蛋白质相互作用界面
参与免疫细胞受体信号传导、癌基因和抑制基因。我们将真正实施
革命性的、全新的“蛋白质绘画”技术,用于快速直接测序隐藏的天然基因
蛋白质-蛋白质相互作用热点,起源于 NCI R21 IMAT CA177535。我们的技术
采用以前未开发的小分子 (12 Å) 芳基烃染料或“涂料”进行剪切,并且 MS
序列,仅是两个或多个相互作用的天然蛋白质之间隐藏的未修饰的接触界面。
蛋白质涂装采用全新原理,可产生更高的特异性和三倍
与化学足迹法相比,阳性命中数更高。涂料化学具有极其
高亲和力(快速结合速率和非常慢的解离速率,比大多数蛋白质-蛋白质高 10 到 100 倍)
互动)。当与天然预形成蛋白质复合物混合仅 5 分钟时,该涂料就不会发生变化。
共价包被蛋白质上的所有外部位点而不改变复合物的 3D 构象,但不能
获得溶剂无法进入的隐藏的蛋白质-蛋白质相互作用域。每个油漆分子跨越
3个氨基酸或更少,并且对蛋白酶切割共有位点具有高亲和力。绘画之后,
未结合的油漆被洗掉,蛋白质被解离。这使得油漆分子涂层
不参与界面的表面。解离后,蛋白质被线性化,用
蛋白水解酶,并通过 MS 测序。涂料分子在反应后仍保持非共价键合
蛋白质变性。胰蛋白酶等蛋白水解酶不会切割蛋白质的区域。
“绘”。因此,在蛋白水解后,从 MS 中产生的肽将完全由
蛋白质紧密接触的未修饰的相对点。所有原始 R21 目标和
里程碑已全部实现。发现蛋白质涂色和
通过晶体结构预测接触点,对真正的阳性热点具有 97% 的特异性。我们发现
进化上保守的三向热点并通过创建肽和验证其功能重要性
阻断相互作用并消除信号传导的单克隆抗体。在Aim1下,我们会发现新奇的热点
与三种类型的相互作用蛋白复合物具有广泛治疗相关性的序列:1) 细胞表面
参与肿瘤免疫细胞抑制的受体 (PD1/PDL-1,PDL-2) , 2) Hippo 癌症抑制因子
途径蛋白,以及 3) 最近阐明的癌基因 Folliculin。在目标 2 下,我们将验证其功能
(候选药物)我们通过创建肽和单克隆抗体发现的相互作用热点的重要性
与相互作用蛋白质的相对热点面结合的抗体。我们将验证这些配体
会抑制蛋白质复合物的形成。对于PD1/PDL-1,PDL-2细胞表面复合物,我们将扩展
首次对培养的活细胞中的细胞间相互作用接触点进行蛋白质绘制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lance Allen Liotta其他文献
Lance Allen Liotta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lance Allen Liotta', 18)}}的其他基金
Targeting Rab6-km23-1-mediated compartmentalized trafficking as a novel therapeutic approach to Alzheimers Disease
靶向 Rab6-km23-1 介导的区室化运输作为阿尔茨海默病的新型治疗方法
- 批准号:
9756263 - 财政年份:2018
- 资助金额:
$ 9.45万 - 项目类别:
Protein painting identifies therapeutic targets at protein-protein interfaces
蛋白质绘画识别蛋白质-蛋白质界面的治疗靶点
- 批准号:
9338200 - 财政年份:2016
- 资助金额:
$ 9.45万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
9085212 - 财政年份:2015
- 资助金额:
$ 9.45万 - 项目类别:
Probes to target the 3-way hotspot of IL1RacP to abolish aberrant interleukin inflammation
靶向 IL1RacP 3 路热点以消除异常白细胞介素炎症的探针
- 批准号:
8944833 - 财政年份:2015
- 资助金额:
$ 9.45万 - 项目类别:
Protein Painting reveals hidden protein-protein interaction domains
蛋白质绘画揭示了隐藏的蛋白质-蛋白质相互作用域
- 批准号:
8728792 - 财政年份:2013
- 资助金额:
$ 9.45万 - 项目类别:
Protein Painting reveals hidden protein-protein interaction domains
蛋白质绘画揭示了隐藏的蛋白质-蛋白质相互作用域
- 批准号:
8547427 - 财政年份:2013
- 资助金额:
$ 9.45万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8548317 - 财政年份:2012
- 资助金额:
$ 9.45万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8433072 - 财政年份:2012
- 资助金额:
$ 9.45万 - 项目类别:
Nanotrap technology for one step preservation and amplification of cancer biomark
Nanotrap 技术可一步保存和扩增癌症生物标志物
- 批准号:
8723137 - 财政年份:2012
- 资助金额:
$ 9.45万 - 项目类别:
Implementation of phosphoprotein preservation technology for cancer biospecimens
癌症生物样本磷蛋白保存技术的实现
- 批准号:
8311650 - 财政年份:2011
- 资助金额:
$ 9.45万 - 项目类别:
相似海外基金
Discovery of nonnatural amino acids promoting alubmin binding
发现促进白蛋白结合的非天然氨基酸
- 批准号:
20K19926 - 财政年份:2020
- 资助金额:
$ 9.45万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineering RNA-binding proteins with unnatural amino acids and expanded genetic codes
用非天然氨基酸和扩展遗传密码改造 RNA 结合蛋白
- 批准号:
511377-2017 - 财政年份:2017
- 资助金额:
$ 9.45万 - 项目类别:
University Undergraduate Student Research Awards
Monitoring and Tuning a Gas-Binding Heme Protein with Unnatural Amino Acids
用非天然氨基酸监测和调节气体结合血红素蛋白
- 批准号:
9231766 - 财政年份:2016
- 资助金额:
$ 9.45万 - 项目类别:
Research Initiation Award: Toward Bionanoscience - Binding of Amino Acids with Graphene and N-doped Graphene
研究启动奖:迈向生物纳米科学——氨基酸与石墨烯和氮掺杂石墨烯的结合
- 批准号:
1601071 - 财政年份:2016
- 资助金额:
$ 9.45万 - 项目类别:
Standard Grant
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2015
- 资助金额:
$ 9.45万 - 项目类别:
Postgraduate Scholarships - Doctoral
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2014
- 资助金额:
$ 9.45万 - 项目类别:
Postgraduate Scholarships - Doctoral
Unnatural Amino Acids of Tyrosine with Salicylic Acid into Cognate Peptide Binding Sequences to Observe Benefit in Cell-Permeability and Utility Towards Inhibitor Design
将酪氨酸的非天然氨基酸与水杨酸形成同源肽结合序列,以观察细胞渗透性和抑制剂设计实用性的益处
- 批准号:
443453-2013 - 财政年份:2013
- 资助金额:
$ 9.45万 - 项目类别:
Postgraduate Scholarships - Doctoral
IDENTIFICATION OF CONSERVED AMINO-ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
7164303 - 财政年份:2005
- 资助金额:
$ 9.45万 - 项目类别:
IDENTIFICATION OF CONSERVED AMINO-ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
6973859 - 财政年份:2004
- 资助金额:
$ 9.45万 - 项目类别:
IDENTIFICATION OF CONSERVED AMINO ACIDS IN AN LPS BINDING CLEFT
LPS 结合裂缝中保守氨基酸的鉴定
- 批准号:
6644340 - 财政年份:2002
- 资助金额:
$ 9.45万 - 项目类别: